NNextResearch

Manipal Health Enterprises (Manipal Hospitals) MANIPALHOS

India's largest hospital network by beds (~13,000 licensed, 49 hospitals) and No. 2 by revenue; leads Bengaluru, Kolkata and Pune; listed Aug 2026

Mapped in 1 theme: Hospitals & Healthcare.

From publicly available information

Where Manipal Health Enterprises (Manipal Hospitals) sits in the supply chain

Manipal Health Enterprises (Manipal Hospitals) appears in 1 supply-chain layer in one theme, Hospitals & Healthcare.

Revenue and profit

₹ CrFY22FY23FY24FY25FY26
Revenue3,9754,8066,1728,24210,336
Net profit5424295331,082917

Latest-year revenue ₹10,336 Cr (FY26, company-wide).

Strengths

  • Scale and metro leadership built through Columbia Asia, AMRI, Medica and Sahyadri acquisitions
  • ~13,000 licensed beds across 49 hospitals (Mar 2026) give room to add capacity on existing campuses
  • Most of the ~₹8,000 Cr fresh issue repays group borrowings; part buys out minority holders in Sahyadri Hospitals

Risks

  • Karnataka still brings close to half of revenue
  • Leverage and integration of Sahyadri and other acquired hospitals
  • Trades at a premium to listed peers - see the figures

Common questions

What does Manipal Health Enterprises (Manipal Hospitals) do?

India's largest hospital network by beds (~13,000 licensed, 49 hospitals) and No. 2 by revenue; leads Bengaluru, Kolkata and Pune; listed Aug 2026.

Where does Manipal Health Enterprises (Manipal Hospitals) sit in the supply chain?

Manipal Health Enterprises (Manipal Hospitals) (NSE: MANIPALHOS) is mapped in 1 supply-chain layer: Multi-specialty hospital chains (Hospitals & Healthcare).

Who are Manipal Health Enterprises (Manipal Hospitals)'s peers?

In the Multi-specialty hospital chains layer of Hospitals & Healthcare: Apollo Hospitals Enterprise, Max Healthcare Institute, Fortis Healthcare, Global Health (Medanta), Narayana Hrudayalaya (Narayana Health), Aster DM Quality Care and 5 more.

What is Manipal Health Enterprises (Manipal Hospitals)'s market cap and valuation?

As of 6 Nov 2026: market cap ₹85,117 Cr, P/E 96.1x, ROCE 12.1%, ROE 12.7%, dividend yield 0%.